MicroRNAs in equine Endometritis: A review of pathophysiology and molecular insights for diagnostic and therapeutic strategies.

This research article provides a comprehensive review of the role and impact of microRNAs in equine endometritis, a significant cause of infertility in mares, and explores their diagnostic and therapeutic potential for the condition.

Pathomorphological Findings in Equine Endometritis

• The paper begins with an analysis of the pathomorphological features of equine endometritis, a chronic inflammatory condition affecting the uterus of mares that can contribute to infertility. This condition is primarily caused by the interference of certain infectious agents with the mare’s innate immune system. These agents can trigger a long-lasting systemic inflammatory response through the blood or cell degeneration, ultimately bringing about endometritis due to the action of bacterial endotoxins.

The Role of MicroRNAs in Equine Endometritis

• Special focus is given to the expression and effects of several specific microRNAs (miRNAs) in endometritis, including eca-miR-17, eca-miR-223, eca-miR-200a, eca-miR-155, and eca-miR-205. MicroRNAs are small, non-coding RNA molecules that play an integral role in many biological functions, including the post-transcriptional regulation of gene expression. They primarily operate by inhibiting transcription and translation processes, hence exerting significant influence over gene expression.

Therapeutic Potential of MicroRNAs

• The review then moves on to discuss the therapeutic role of microRNAs in cases of equine endometritis. The miRNAs are understood to play a vital regulatory role in a wide range of inflammatory diseases by adjusting the molecular mechanism of cytokines that bring about inflammation through various signal pathways. This attribute makes miRNAs attractive potential targets for novel diagnostic and therapeutic strategies for equine endometritis.

Future Research Directions

• Lastly, the manuscript underlines the urgent need for more progressive genetic technologies and the development of brand-new pharmaceutical preparations. Such advancements would greatly enhance our understanding of the genes encoded by these microRNAs, and potentially unlock new ways of preventing and treating equine endometritis. The paper concludes with a focus on the effectiveness of miRNAs in controlling and diagnosing the condition early, as well as their use in preventative measures.